When they divided cases into those with IgA+ and IgA− microbiota, cancer cases IgA+ had an altered composition, lower richness and α-diversity of their fecal microbiota, significantly more marked than cases with the IgA-negative microbiota, after adjustment for estrogen levels and other variables [53]. Here, CD79A is linked to cancer.